- Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial
2026/06/11 by Marco Stortz, Andreas Kommer, Myriam Meineck +10 · 2 voices
Medicine · Psychology · #Adverse effect #Autoantibody #Autoimmune Neurological Disorders and Treatments #COVID-19 and Mental Health #Crossover study #Immunoadsorption #Long-Term Effects of COVID-19 #Prospective cohort study #Randomized controlled trial #Severity of illness